CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Operating activities
Net income (loss)	$ (120,434)	$ 85
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Accretion of debt discount	1,298	3,413
Change in fair value of financial instruments	22,669	(17,700)
Gain from pre-existing settlement		(80,229)
Gain from extinguishment of debt	(13,869)
Change in fair value of contingent consideration	1,600	1,000
Amortization of intangible assets	5,953	1,408
Depreciation	344	310
Stock-based compensation	8,525	7,894
Unrealized foreign currency gain	(10,968)	(1,301)
Other non-cash adjustments	23	474
Changes in operating assets and liabilities:
Accounts receivable, net	(17,882)	4,731
Inventory	7,635	618
Prepaid expenses and other current assets	(324)	(3,826)
Other assets	2,358	(2,150)
Accounts payable and accrued expenses	10,529	13,060
Deferred revenue	(3,794)	(3,643)
Deferred rent and lease incentives		(150)
Net cash used in operating activities	(106,337)	(76,006)
Investing activities
Purchases of investment securities, available-for-sale	(89,962)	(23,600)
Maturities of investment securities, available-for-sale	76,498	80,605
Restricted cash and investments	90,000	(165,229)
Purchase of Contrave - net	(3,414)	(60,435)
Purchase of property and equipment		(286)
Net cash provided by (used) in investing activities	73,122	(168,945)
Financing activities
Payment for conversions of 2017 Exchange Notes	(1,375)
Contingent payment to Takeda	(12,900)
Proceeds from convertible debt issuance		120,000
Proceeds from issuance of warrants		41,000
Proceeds from issuance of Series Z Preferred Stock		3,343
Proceeds from issuance of common stock	438	139
Net cash provided by (used in) financing activities	(13,837)	164,482
Effect of exchange rate changes on cash	135	(526)
Net decrease in cash and cash equivalents	(46,917)	(80,995)
Cash and cash equivalents at beginning of period	92,494	155,422
Cash and cash equivalents at end of period	45,577	74,427
Supplemental disclosure of non-cash financing information:
Interest paid	1,000
Conversions of 2017 Exchange Notes	4,689
Liability incurred to acquire Contrave		$ 5,442
Taxes paid	$ 175